Infectious Diseases

502 soru

Soru 321Soru →

An intensivist is reviewing the microbiological data for a 48-year-old male patient on mechanical ventilation. The patient was admitted to the intensive care unit 8 days ago following a motor vehicle collision that resulted in severe head trauma. Three days ago, he developed a new fever of 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), thick endotracheal secretions, and worsening hypoxemia. A chest radiograph at that time revealed a new left lower lobe consolidation. He was empirically started on intravenous vancomycin, cefepime, and tobramycin for suspected ventilator-associated pneumonia (VAP).

Today, the patient is clinically improved. His temperature is 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}), and his oxygen requirements have decreased. The endotracheal aspirate culture obtained prior to antibiotic initiation now shows:

- Heavy growth of *Pseudomonas aeruginosa*
- Moderate growth of *Candida albicans*
- No *Staphylococcus aureus* isolated

Antimicrobial susceptibility testing for the *Pseudomonas aeruginosa* isolate demonstrates susceptibility to cefepime, meropenem, piperacillin-tazobactam, and tobramycin. Blood cultures drawn at the time of the fever have remained sterile.

Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Discontinue vancomycin and tobramycin, and continue cefepime

Cevap

Discontinue vancomycin and tobramycin, and continue cefepime
The correct approach for this clinically improving patient with ventilator-associated pneumonia (VAP) is to de-escalate the empiric antibiotic regimen to targeted monotherapy based on finalized culture and susceptibility results. First, vancomycin should be discontinued because no methicillin-resistant Staphylococcus aureus (MRSA) was isolated. Second, tobramycin can be discontinued; while double antipseudomonal coverage is appropriate for initial empiric therapy in patients at high risk for resistant organisms, definitive therapy should be narrowed to a single active agent (in this case, cefepime) to reduce the risk of nephrotoxicity. Finally, the isolation of Candida albicans from endotracheal secretions represents airway colonization. Candida is a normal commensal of the oropharynx, and treating it with antifungals in this setting is a common error in antimicrobial stewardship.

Adım Adım Çözüm

1
Analyze the need for ongoing MRSA coverage.
The culture showed no growth of Staphylococcus aureus after 3 days.
Empiric MRSA coverage (vancomycin) should be discontinued when respiratory cultures do not isolate MRSA, in order to reduce nephrotoxicity.
2
Determine the optimal definitive therapy for the Pseudomonas isolate.
The isolate is susceptible to cefepime, which the patient is already receiving.
Once a Pseudomonas isolate is proven susceptible to a beta-lactam (cefepime), the second empiric agent (tobramycin) should be discontinued to de-escalate therapy.
3
Evaluate the clinical significance of Candida albicans in the respiratory tract.
Candida in endotracheal aspirates represents airway colonization.
Antifungal therapy is not indicated for Candida isolated from respiratory secretions, as invasive Candida pneumonia is exceptionally rare.

Anahtar Kavram

Antimicrobial de-escalation in VAP involves discontinuing unnecessary MRSA and double-antipseudomonal coverage once susceptibilities are known, and recognizing that respiratory Candida represents colonization.
Tahmini Süre:1m 30s
Soru 322Soru →

An intensive care unit team is conducting morning rounds. The patient is a 68-year-old female who was admitted one week ago following an out-of-hospital cardiac arrest. She was successfully resuscitated and placed on mechanical ventilation. Three days ago, her condition became complicated with a new fever of 39.2°C (102.6°F), worsening hypoxemia, and purulent endotracheal secretions. A chest radiograph demonstrated a new right lower lobe consolidation. Empiric intravenous vancomycin and cefepime were initiated for a presumed ventilator-associated pneumonia.

Today, she exhibits significant clinical improvement. She is afebrile with a temperature of 37.1°C (98.8°F), blood pressure of 128/78 mm Hg, and heart rate of 82/min. Her ventilator settings have been successfully weaned. An endotracheal aspirate culture obtained at the onset of fever demonstrates heavy growth of Pseudomonas aeruginosa. Susceptibility testing shows the organism is susceptible to cefepime, piperacillin-tazobactam, and meropenem, but resistant to levofloxacin. No other organisms are isolated. A nasal swab polymerase chain reaction (PCR) screen for methicillin-resistant Staphylococcus aureus (MRSA) obtained three days ago is negative.

Based on the culture and susceptibility results, which of the following is the most appropriate next step in the pharmacologic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Discontinue vancomycin and continue intravenous cefepime

Cevap

Discontinue vancomycin and continue intravenous cefepime
The most appropriate next step in management is to discontinue vancomycin and maintain the patient on intravenous cefepime. The core principle of antibiotic stewardship in ventilator-associated pneumonia (VAP) is to initiate broad-spectrum empiric coverage (typically an anti-MRSA agent and an antipseudomonal beta-lactam) and then rapidly de-escalate once culture and susceptibility data become available. In this case, the endotracheal culture grew only Pseudomonas aeruginosa that is susceptible to cefepime. Furthermore, the rapid nasal MRSA PCR is negative. A negative MRSA nasal swab has an exceptionally high negative predictive value (>95%) for MRSA pneumonia. Because the patient is clinically improving and the pathogen is fully susceptible to the current beta-lactam, continuing vancomycin offers no added benefit. Discontinuing it minimizes the risk of nephrotoxicity and adheres strictly to stewardship guidelines.

Adım Adım Çözüm

1
Assess the patient's clinical trajectory following the initiation of empiric therapy.
The patient is clinically improving, as evidenced by resolving fever and decreasing oxygen requirements.
Clinical stability is a crucial prerequisite for the safe de-escalation of antimicrobial therapy.
2
Interpret the microbiological culture data and susceptibility results.
The endotracheal culture isolated Pseudomonas aeruginosa that is susceptible to cefepime.
Targeted therapy must be directed at the definitively identified pathogen to ensure efficacy while minimizing broad-spectrum exposure.
3
Evaluate the indication for continued MRSA coverage based on screening and culture data.
The MRSA nasal PCR is negative, and respiratory cultures did not grow MRSA.
A negative MRSA nares screen has a highly reliable negative predictive value (>95%) for MRSA pneumonia, safely allowing the discontinuation of anti-MRSA agents like vancomycin.
4
Determine the optimal definitive antibiotic regimen based on stewardship principles.
Vancomycin should be discontinued, and cefepime should be continued as monotherapy.
De-escalating to monotherapy with a proven effective agent minimizes toxicity and reduces the risk of generating antimicrobial resistance.

Anahtar Kavram

Antimicrobial de-escalation in ventilator-associated pneumonia based on clinical stability, specific culture susceptibilities, and negative MRSA screening.
Soru 323Soru →

A 29-year-old female graduate student presents to the university health clinic complaining of burning with urination and increased urinary frequency for the past 4848 hours. She denies any back pain, nausea, vomiting, or vaginal discharge. Her temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure is 110/70 mm Hg110/70\text{ mm Hg}, and pulse is 78/min78\text{/min}. Physical examination demonstrates mild suprapubic discomfort on deep palpation but no costovertebral angle tenderness. A urine sample collected at an outside urgent care facility three days ago has just returned positive for *Klebsiella pneumoniae*. The microbiology report flags the isolate as an extended-spectrum beta-lactamase (ESBL) producer. Susceptibility testing reveals resistance to ceftriaxone, cefepime, and ciprofloxacin, but confirms susceptibility to nitrofurantoin, fosfomycin, and meropenem. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Oral nitrofurantoin therapy

Cevap

Oral nitrofurantoin therapy is the most appropriate treatment.
The correct approach is to prescribe oral nitrofurantoin. The patient's clinical presentation of dysuria, frequency, and suprapubic pain without fever or flank pain is diagnostic of uncomplicated cystitis. Although the causative pathogen is an ESBL-producing organism, these bacteria often retain susceptibility to nitrofurantoin and fosfomycin. Nitrofurantoin reaches high concentrations in the lower urinary tract and is highly effective for cystitis. Choosing this oral agent allows for convenient outpatient management and adheres to strict antimicrobial stewardship guidelines by avoiding the unnecessary use of broad-spectrum intravenous carbapenems (which must be reserved for severe, systemic infections).

Adım Adım Çözüm

1
Assess the clinical syndrome based on the patient's presentation.
The diagnosis is uncomplicated acute cystitis.
The patient has localized symptoms (dysuria, frequency, suprapubic pain) and lacks systemic signs such as fever, vomiting, or costovertebral angle tenderness that would suggest pyelonephritis.
2
Analyze the microbiology and susceptibility data.
The causative organism is an ESBL-producing *Klebsiella pneumoniae* that is susceptible to oral nitrofurantoin and fosfomycin, as well as intravenous meropenem.
Identifying the specific resistance pattern is crucial for selecting effective pharmacotherapy.
3
Select the optimal antimicrobial agent.
Oral nitrofurantoin is chosen.
Nitrofurantoin provides effective, narrow-spectrum coverage for ESBL cystitis in an outpatient setting, adhering to antimicrobial stewardship by sparing the use of broad-spectrum intravenous carbapenems.

Anahtar Kavram

Uncomplicated cystitis caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae should be treated with narrow-spectrum oral agents like nitrofurantoin or fosfomycin to avoid unnecessary use of intravenous carbapenems.
Tahmini Süre:1m 0s
Soru 324Soru →

Correlate the following clinical presentations of central nervous system and disseminated infections in immunocompromised hosts with their most appropriate primary targeted management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient with untreated HIV and elevated opening pressure on lumbar puncture; cerebrospinal fluid reveals budding yeast with a thick polysaccharide capsule.
A solid organ transplant recipient with a new ring-enhancing brain mass and cavitary pulmonary lesions; aspirate reveals branching, weakly acid-fast filamentous bacteria.
A patient with advanced HIV (CD4 count 45 cells/mm³) presenting with seizures; MRI reveals multiple basilar ring-enhancing lesions with surrounding edema.
A patient with profound neutropenia undergoing leukemia induction chemotherapy who develops facial pain and a rapidly expanding necrotic eschar on the hard palate.
A patient with AIDS presenting with progressive cognitive decline and ataxia; MRI shows asymmetric, non-enhancing white matter lesions without mass effect.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings appropriately match the unique microbiological and radiographic findings of opportunistic infections with their definitive standard-of-care therapies.
Each correct pairing accurately identifies the opportunistic pathogen from its characteristic diagnostic clues and assigns the current guideline-directed first-line therapy.

Adım Adım Çözüm

1
Analyze the host immune status and specific clinical clues in each vignette.
Identified pathogens: Cryptococcus, Nocardia, Toxoplasma, Mucorales, and JC virus.
Different defects in cellular immunity (HIV, transplantation) or neutrophils (chemotherapy) predispose to specific sets of opportunistic pathogens with characteristic presentations.
2
Select the optimal targeted therapy for each identified pathogen.
Matched Cryptococcus to Ampho B + Flucytosine, Nocardia to TMP-SMX, Toxoplasma to Pyrimethamine + Sulfadiazine, Mucor to Surgery + Ampho B, and JC virus to ART.
Definitive management requires knowing first-line antimicrobials and distinguishing medical-only therapy from conditions mandating surgical intervention.

Anahtar Kavram

Management of central nervous system and disseminated opportunistic infections in immunocompromised hosts
Tahmini Süre:2m 0s
Soru 325Soru →

A 35-year-old man with untreated HIV infection is brought to the emergency department by his partner due to a 2-week history of progressively worsening headache, fever, and confusion. His temperature is 38.6°C (101.5°F), blood pressure is 120/78 mmHg, and heart rate is 102/min. Physical examination reveals nuchal rigidity and bilateral sixth cranial nerve palsies. Laboratory studies show a CD4 cell count of 28/mm³. A lumbar puncture is performed, and cerebrospinal fluid (CSF) analysis reveals a leukocyte count of 350/mm³ (85% lymphocytes), glucose of 30 mg/dL, and protein of 150 mg/dL. CSF acid-fast bacilli smear is positive. The patient is admitted to the intensive care unit and started on isoniazid, rifampin, pyrazinamide, ethambutol, and intravenous dexamethasone. Which of the following is the most appropriate timing for initiating antiretroviral therapy in this patient?

Cevabı ve açıklamayı göster

Cevap: At approximately 8 weeks after starting anti-tuberculous therapy

Cevap

At approximately 8 weeks after starting anti-tuberculous therapy
The correct timing is to delay ART for approximately 8 weeks. In patients with HIV who develop tuberculous meningitis, initiating antiretroviral therapy (ART) early leads to a rapid restoration of immune function. This robust inflammatory response directed against mycobacterial antigens in the central nervous system is known as Immune Reconstitution Inflammatory Syndrome (IRIS). In the closed space of the skull, the resulting edema can cause severe neurological deterioration, herniation, and death. Therefore, current guidelines mandate delaying ART for at least 8 weeks in all patients with TB meningitis, regardless of how low their CD4 cell count is.

Adım Adım Çözüm

1
Identify the patient's primary diagnosis and immune status.
The patient has tuberculous (TB) meningitis and advanced HIV with a CD4 count of 28/mm³.
CSF findings (lymphocytic pleocytosis, low glucose, high protein) with a positive AFB smear in an HIV-positive patient confirm TB meningitis. The CD4 count dictates HIV severity.
2
Determine the standard rules for antiretroviral therapy (ART) initiation in HIV-TB coinfection.
Generally, for pulmonary TB, ART is started within 2 weeks if CD4 < 50/mm³, and within 8 weeks if CD4 ≥ 50/mm³.
Early ART in pulmonary TB reduces HIV-related mortality, though it carries a risk of immune reconstitution inflammatory syndrome (IRIS).
3
Apply the specific exception for central nervous system (CNS) tuberculosis.
Because the patient has TB meningitis, the standard CD4-based rule is superseded. ART must be delayed for approximately 8 weeks.
CNS-IRIS in the closed space of the cranial vault can cause severe cerebral edema and herniation. Clinical trials have shown that early ART in TB meningitis increases mortality.

Anahtar Kavram

In patients with HIV and tuberculous meningitis, antiretroviral therapy (ART) should be delayed for approximately 8 weeks after starting anti-tuberculous therapy, regardless of the CD4 count, to prevent fatal CNS immune reconstitution inflammatory syndrome (IRIS).
Soru 326Soru →

A 54-year-old woman is evaluated in the oncology ward for a new-onset fever. She is currently on day 10 of induction chemotherapy for acute myeloid leukemia. Her temperature is 38.8°C (101.8°F), blood pressure is 105/65 mmHg, and heart rate is 112/min. Laboratory analysis shows a white blood cell count of 400/mm³ with an absolute neutrophil count (ANC) of 150/mm³. She has a central venous port in her right internal jugular vein.

Arrange the following interventions in the most appropriate chronological sequence for managing this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing neutropenic fever is to first obtain appropriate blood cultures, immediately follow with empiric antipseudomonal antibiotics, later tailor the regimen based on culture results, and finally add empiric antifungal therapy if the fever persists beyond 4 to 7 days.
The standard protocol for neutropenic fever requires an immediate, sequential approach. Blood cultures must be drawn first to identify the organism, followed urgently by empiric antipseudomonal antibiotics to prevent septic shock. Once culture results return (usually 48-72 hours later), the antibiotics are tailored. Finally, if the patient remains febrile and neutropenic after 4 to 7 days, empiric antifungal therapy is added.

Adım Adım Çözüm

1
Obtain blood cultures from the central venous port and a peripheral vein.
Samples are sent for microbiologic analysis.
Blood cultures must be drawn before starting antibiotics to prevent sterilization of the sample and allow for the identification of the causative pathogen.
2
Administer empiric intravenous antipseudomonal therapy (e.g., cefepime).
The patient receives broad-spectrum antibacterial coverage.
Neutropenic patients lack the immune response to control infections; delaying empiric antibiotics significantly increases the risk of mortality.
3
Tailor the antibacterial regimen based on finalized culture and susceptibility results.
Antibiotics are de-escalated or adjusted.
Once the pathogen and its susceptibilities are known, targeted therapy reduces the risk of resistance and medication toxicity, adhering to principles of antimicrobial stewardship.
4
Initiate empiric intravenous antifungal therapy if the patient remains febrile after 4 to 7 days.
The patient receives coverage for invasive fungal pathogens.
Persistent fever in a profoundly neutropenic patient despite broad-spectrum antibiotics suggests a high likelihood of an underlying fungal infection, most commonly Candida or Aspergillus species.

Anahtar Kavram

The chronological management algorithm for neutropenic fever prioritizes immediate cultures and empiric antipseudomonal antibiotics, followed by culture-directed tailoring, and reserves empiric antifungals for those who remain febrile after 4 to 7 days.
Tahmini Süre:1m 0s
Soru 327Soru →

A 72-year-old man is evaluated in the hospital on day 3 of admission for community-acquired pneumonia. He initially presented to the emergency department with a 2-day history of fever, productive cough, and shortness of breath. His medical history is significant for hypertension and mild chronic obstructive pulmonary disease. On admission, his temperature was 38.9∘C38.9^\circ\text{C} (102∘F102^\circ\text{F}), blood pressure was 118/76 mmHg118/76\text{ mmHg}, pulse was 102/min102/\text{min}, and respiratory rate was 22/min22/\text{min}. Oxygen saturation was 92%92\% on room air. Chest radiography revealed a right lower lobe consolidation. He was empirically started on intravenous ceftriaxone and intravenous azithromycin. Today, the patient is afebrile, his pulse is 82/min82/\text{min}, and his respiratory rate is 16/min16/\text{min}. He is resting comfortably and eating a regular diet. Blood cultures drawn on admission are now growing *Streptococcus pneumoniae*. Susceptibility testing shows the organism is highly susceptible to penicillin, amoxicillin, ceftriaxone, and levofloxacin, but resistant to azithromycin. Which of the following is the most appropriate next step in antibiotic management?

Cevabı ve açıklamayı göster

Cevap: Discontinue current antibiotics and begin oral amoxicillin

Cevap

The most appropriate step is to discontinue current antibiotics and begin oral amoxicillin.
The correct approach is to transition the patient to oral amoxicillin. This decision is based on two core principles of antimicrobial stewardship: IV-to-PO conversion and de-escalation (spectrum narrowing). The patient has demonstrated clinical stability (afebrile, normalizing vital signs) and is tolerating an oral diet, satisfying the criteria for transition to oral therapy. Furthermore, the blood cultures have identified Streptococcus pneumoniae that is highly susceptible to penicillin. Therefore, empiric therapy (ceftriaxone and azithromycin) should be discontinued in favor of amoxicillin, which is the most appropriate, narrow-spectrum oral agent to complete the treatment course.

Adım Adım Çözüm

1
Assess the patient's clinical stability and ability to take oral medications.
The patient is afebrile, hemodynamically stable, has a normal respiratory rate, and is eating a regular diet.
Patients hospitalized with pneumonia who demonstrate clinical improvement and can tolerate oral intake should be transitioned from intravenous to oral antibiotics.
2
Review culture and susceptibility data to direct targeted therapy.
Blood cultures isolate S. pneumoniae that is highly susceptible to penicillin and amoxicillin.
Empiric broad-spectrum therapy should be de-escalated to the narrowest effective agent once an organism is identified to prevent collateral damage (e.g., C. difficile infection) and antimicrobial resistance.
3
Select the optimal oral agent based on the susceptibility profile.
Oral amoxicillin is selected.
Amoxicillin is a narrow-spectrum beta-lactam highly effective against penicillin-susceptible S. pneumoniae, making it superior to broader agents like fluoroquinolones or beta-lactamase inhibitor combinations.

Anahtar Kavram

In patients treated for community-acquired pneumonia, therapy should be transitioned from intravenous to targeted, narrow-spectrum oral antibiotics once clinical stability is achieved and culture susceptibilities are known.
Soru 328Soru →

A 54-year-old man presents to the clinic with a 5-day history of fever, severe fatigue, drenching sweats, and dark urine. He recently returned from a 2-week camping trip in Nantucket, Massachusetts. Two days ago, he was evaluated at an urgent care center where a 6-cm expanding erythematous plaque with central clearing was noted on his right thigh. He was prescribed oral doxycycline for presumed early localized Lyme disease. Despite compliance with the medication, his fever and fatigue have persisted and worsened. His temperature is 38.9°C (102.0°F), blood pressure is 116/74 mm Hg, and pulse is 108/min. Physical examination reveals pale conjunctivae, mild scleral icterus, and a fading erythematous patch on the right thigh. There is no respiratory distress. Laboratory studies show:

Hemoglobin: 9.2 g/dL
Platelets: 88,000/mm³
Leukocytes: 4,500/mm³
Total bilirubin: 3.4 mg/dL
Indirect bilirubin: 2.8 mg/dL
Lactate dehydrogenase: 650 U/L

A peripheral blood smear demonstrates pleomorphic intraerythrocytic ring forms and occasional tetrads. Which of the following is the most appropriate pharmacotherapy for this patient's current condition?

Cevabı ve açıklamayı göster

Cevap: Atovaquone and azithromycin

Cevap

Atovaquone and azithromycin
The patient's presentation of hemolytic anemia (elevated LDH, elevated indirect bilirubin, jaundice) and thrombocytopenia following a tick exposure in an endemic region (Northeastern United States) is classic for babesiosis. The diagnosis is confirmed by the peripheral blood smear demonstrating intraerythrocytic tetrads (often referred to as 'Maltese crosses'). Because the Ixodes scapularis tick transmits both Borrelia burgdorferi and Babesia microti, coinfection is common. The standard first-line treatment for mild-to-moderate babesiosis in a hemodynamically stable patient is a combination of atovaquone and azithromycin.

Adım Adım Çözüm

1
Analyze the clinical presentation and geographic history.
The patient has a history of a tick bite in an endemic area (Nantucket) causing an erythema migrans rash (Lyme disease), but now presents with new-onset fever, jaundice, and dark urine despite appropriate Lyme treatment.
Identifying symptoms that do not align with simple early localized Lyme disease suggests a possible tick-borne coinfection.
2
Interpret the laboratory findings and peripheral blood smear.
Labs reveal a hemolytic anemia (low hemoglobin, elevated indirect bilirubin, elevated LDH) and thrombocytopenia. The blood smear shows intraerythrocytic tetrads (Maltese crosses).
These findings are pathognomonic for Babesiosis, caused by the Babesia microti parasite, which is co-transmitted with Borrelia burgdorferi by the Ixodes scapularis tick.
3
Determine the most appropriate pharmacotherapy.
The patient is hemodynamically stable without respiratory distress, indicating mild-to-moderate disease, which is best treated with atovaquone and azithromycin.
While clindamycin and quinine are used for severe babesiosis, their high toxicity profile makes them inappropriate for stable patients.

Anahtar Kavram

Diagnosis and management of babesiosis as a tick-borne coinfection with Lyme disease.
Soru 329Soru →

A 68-year-old man is admitted to the hospital due to a 3-week history of low-grade fevers, progressive fatigue, and dyspnea on exertion. He has a history of hypertension and osteoarthritis. His temperature is 38.2°C (100.8°F), blood pressure is 128/76 mm Hg, pulse is 92/min, and respirations are 16/min. Physical examination reveals a new grade 3/6 holosystolic murmur best heard at the cardiac apex and radiating to the axilla. Splinter hemorrhages are noted on the fingernails. Transesophageal echocardiography demonstrates a 1.2-cm mobile vegetation on the anterior leaflet of the mitral valve with moderate mitral regurgitation. Three sets of blood cultures are obtained, and the patient is started on empiric intravenous vancomycin and cefepime. Forty-eight hours later, all three blood cultures grow *Enterococcus faecalis*. Antimicrobial susceptibility testing results are as follows:

AntimicrobialInterpretation
AmpicillinSusceptible
PenicillinSusceptible
VancomycinSusceptible
GentamicinHigh-level resistance
StreptomycinSusceptible

Which of the following is the most appropriate definitive pharmacotherapy for this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous ampicillin and ceftriaxone

Cevap

The most appropriate therapy is intravenous ampicillin and ceftriaxone.
The correct definitive therapy is intravenous ampicillin and ceftriaxone. The patient has infective endocarditis caused by *Enterococcus faecalis*. Enterococci are intrinsically tolerant to the bactericidal activity of cell-wall active agents (like ampicillin or vancomycin) when used alone. Therefore, successful treatment of enterococcal endocarditis requires a synergistic bactericidal regimen. The traditional synergistic combination is ampicillin plus an aminoglycoside (e.g., gentamicin). However, this patient's isolate demonstrates high-level aminoglycoside resistance (HLAR) to gentamicin, meaning gentamicin will not provide synergy. The combination of ampicillin and ceftriaxone provides synergistic bactericidal activity against *E. faecalis* through the dual saturation of essential penicillin-binding proteins (PBPs), specifically PBP4 and PBP2/3. This combination is highly effective, represents the standard of care for HLAR isolates, and avoids the nephrotoxicity associated with aminoglycosides.

Adım Adım Çözüm

1
Identify the primary diagnosis based on clinical and diagnostic findings.
The patient has infective endocarditis caused by Enterococcus faecalis.
The clinical presentation (fever, new murmur, splinter hemorrhages), echocardiogram findings (mitral valve vegetation), and positive blood cultures fulfill the modified Duke criteria for definite infective endocarditis.
2
Evaluate the antimicrobial susceptibility profile of the isolate.
The isolate is susceptible to ampicillin but demonstrates high-level resistance to gentamicin.
Enterococci are intrinsically tolerant to beta-lactams and require a second agent for bactericidal synergy. The susceptibility profile dictates which second agent can be effectively used.
3
Select the optimal targeted, synergistic pharmacotherapy.
Intravenous ampicillin and ceftriaxone is the correct regimen.
Because high-level gentamicin resistance precludes traditional aminoglycoside synergy, dual beta-lactam therapy with ampicillin and ceftriaxone is indicated to achieve synergistic saturation of penicillin-binding proteins.

Anahtar Kavram

Treatment of Enterococcus faecalis infective endocarditis requires a synergistic bactericidal regimen, typically ampicillin plus ceftriaxone when the isolate exhibits high-level aminoglycoside resistance.
Soru 330Soru →

Match each of the following high-risk infectious exposure scenarios with the most appropriate immediate management or post-exposure prophylaxis (PEP) step.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 28-year-old resident physician sustains a deep needlestick injury after drawing blood from a patient with chronic hepatitis B and negative HIV serology. The physician's anti-HBs titer was 45 mIU/mL after their vaccination series five years ago.
A 32-year-old pregnant woman at 12 weeks gestation reports that her 5-year-old nephew, whom she babysits daily, developed a 'slapped cheek' rash yesterday. Her own childhood infection history is unknown.
A 45-year-old camper awakens in his tent to find a bat flying around. He captures the bat but notices two small puncture marks on his lower leg. He has never received any specialized pre-exposure vaccinations.
A 21-year-old college student presents to student health requesting antibiotics. He shares an apartment with a classmate who was admitted to the ICU yesterday with a purpuric rash and bacterial meningitis.
A 55-year-old renal transplant recipient on maintenance immunosuppression is visited by a grandchild who develops vesicular lesions later that evening. The patient has never had chickenpox or the varicella vaccine.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The resident physician requires no PEP. The pregnant woman requires Parvovirus B19 serology. The camper requires HRIG and rabies vaccine. The college roommate requires meningococcal chemoprophylaxis (ciprofloxacin, rifampin, or ceftriaxone). The transplant recipient requires VZIG.
Each correct match directly pairs the specific exposure risk with the host's current immune status to determine the exact protocol recommended by the CDC.

Adım Adım Çözüm

1
Evaluate the hepatitis B exposure.
The physician is a documented responder (anti-HBs > 10 mIU/mL).
Documented responders are completely protected against HBV and do not need HBIG or a booster dose, regardless of the source patient's status.
2
Evaluate the parvovirus B19 exposure.
Maternal serologic testing is indicated.
You must establish whether the mother is at risk of acute infection, which would necessitate serial fetal ultrasounds to monitor for hydrops fetalis.
3
Evaluate the bat exposure.
Rabies PEP is required.
Because bat bites can be imperceptible, finding a bat in a sleeping quarters is sufficient grounds for HRIG and vaccination if the bat cannot be immediately tested and confirmed negative.
4
Evaluate the meningococcal exposure.
Antibiotic prophylaxis is required.
Living in the same household or sharing oral secretions qualifies as high-risk close contact, necessitating eradication of nasopharyngeal carriage.
5
Evaluate the varicella exposure in an immunosuppressed host.
VZIG administration is required.
Immunocompromised patients lacking immunity are at high risk for visceral dissemination (e.g., pneumonitis, encephalitis). Live vaccines are contraindicated, making passive immunization the standard of care.

Anahtar Kavram

Post-exposure prophylaxis and immediate management of high-yield infectious diseases
Soru 331Soru →

Emergency medical services bring a 61-year-old man to the emergency department after his family found him confused and febrile. His wife reports that he complained of a severe, throbbing headache yesterday before becoming progressively somnolent this morning. His past medical history includes hypertension and type 2 diabetes mellitus. Temperature is 39.4∘C39.4^{\circ}\text{C} (102.9∘F102.9^{\circ}\text{F}), blood pressure is 138/86 mmHg138/86\text{ mmHg}, pulse is 112/min112/\text{min}, and respirations are 18/min18/\text{min}. On physical examination, the patient is lethargic and oriented only to person. He strongly resists passive neck flexion. Fundoscopic examination reveals bilateral blurring of the optic disc margins. Neurologic examination demonstrates a left-sided facial droop and decreased strength in the left upper extremity compared to the right. Arrange the following steps in the most appropriate chronological order for managing this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing this patient is to first obtain peripheral blood cultures, immediately follow with empiric intravenous antibiotics and dexamethasone, then obtain a noncontrast CT scan of the head, and finally perform a lumbar puncture.
The correct sequence for managing suspected bacterial meningitis in a patient with signs of increased intracranial pressure (papilledema) or focal neurologic deficits is: (1) Blood cultures, (2) Empiric antibiotics and dexamethasone, (3) CT scan of the head, and (4) Lumbar puncture. Obtaining blood cultures first maximizes the chance of identifying the causative organism. Because a CT scan will delay the lumbar puncture, empiric antibiotics must be administered immediately after blood cultures to prevent increased morbidity and mortality. A CT scan is mandatory before the lumbar puncture in this patient due to his papilledema, altered mental status, and focal weakness, which suggest increased intracranial pressure and a high risk of brain herniation. Finally, the lumbar puncture can be safely performed to analyze the cerebrospinal fluid once a mass lesion is ruled out.

Adım Adım Çözüm

1
Identify the primary suspected diagnosis.
The patient has the classic triad of meningitis (fever, nuchal rigidity, altered mental status).
Recognizing acute bacterial meningitis establishes the need for an urgent diagnostic and therapeutic pathway.
2
Assess for indications that require neuroimaging prior to a lumbar puncture.
The patient has papilledema, altered mental status, and focal neurologic deficits (facial droop, arm weakness).
These findings raise suspicion for a focal mass lesion or severely increased intracranial pressure, which increases the risk of fatal brain herniation if a lumbar puncture is performed blindly.
3
Determine the optimal sequencing of interventions.
Blood cultures must be drawn first, followed immediately by empiric antibiotics, then the CT scan, and lastly the lumbar puncture.
Antibiotics must not be delayed by the CT scan. Drawing blood cultures first prevents sterilization of the blood, and giving antibiotics immediately prevents further neurologic decline while awaiting imaging.

Anahtar Kavram

Algorithm for suspected bacterial meningitis with indications for imaging prior to lumbar puncture
Soru 332Soru →

A 42-year-old man is evaluated in the hospital for ongoing management of right knee septic arthritis. He originally presented 3 days ago with an acutely painful, swollen right knee and a temperature of 38.8°C (101.8°F). Initial arthrocentesis revealed purulent synovial fluid with 95,000 leukocytes/mm³, and a Gram stain demonstrated Gram-positive cocci in clusters. He underwent prompt arthroscopic irrigation and debridement, and was empirically started on intravenous vancomycin. Today, the patient reports feeling much better, his knee pain has decreased, and he has been afebrile for 24 hours. Final synovial fluid cultures are positive for Staphylococcus aureus. Antimicrobial susceptibility testing shows that the isolate is resistant to penicillin but susceptible to oxacillin, cefazolin, clindamycin, and vancomycin. Which of the following is the most appropriate next step in the antibiotic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Switch to intravenous cefazolin

Cevap

Switch to intravenous cefazolin
The patient's synovial fluid cultures have finalized, revealing Methicillin-Susceptible Staphylococcus aureus (MSSA), as indicated by its susceptibility to oxacillin and cefazolin. In the setting of deep tissue infections or bacteremia caused by MSSA, targeted therapy with a beta-lactam antibiotic—such as intravenous cefazolin, nafcillin, or oxacillin—is the definitive treatment of choice. These agents offer superior and more rapid bactericidal activity, better tissue penetration, and lower rates of clinical failure compared to vancomycin. Transitioning the patient to intravenous cefazolin represents appropriate antimicrobial stewardship by de-escalating from a broad-spectrum empiric regimen to the most effective, targeted, narrow-spectrum agent.

Adım Adım Çözüm

1
Interpret the final culture and susceptibility results.
The pathogen is identified as Methicillin-Susceptible Staphylococcus aureus (MSSA) because it is susceptible to oxacillin and cefazolin.
Accurate identification of the pathogen's resistance profile is essential for tailoring definitive antibiotic therapy.
2
Apply principles of antimicrobial stewardship to the current empiric regimen.
The current regimen of intravenous vancomycin must be evaluated against the targeted susceptibility profile.
Empiric broad-spectrum therapy should be de-escalated to the narrowest, most effective targeted agent once cultures finalize.
3
Select the optimal targeted therapy for an invasive MSSA infection.
Intravenous cefazolin (or an anti-staphylococcal penicillin) is selected over continuing vancomycin or using other broad-spectrum agents.
Beta-lactams exhibit more rapid bactericidal activity and better clinical outcomes than vancomycin for MSSA infections.

Anahtar Kavram

De-escalation of broad-spectrum empiric coverage (e.g., vancomycin) to a targeted, narrow-spectrum beta-lactam (e.g., cefazolin) is the standard of care for invasive Methicillin-Susceptible Staphylococcus aureus (MSSA) infections.
Soru 333Soru →

During a preoperative assessment, a 74-year-old male is reviewed by the surgical team three days before an elective left total hip arthroplasty. He has longstanding osteoarthritis, diet-controlled type 2 diabetes mellitus, and mild benign prostatic hyperplasia. The patient feels well and explicitly denies any current urinary urgency, dysuria, increased frequency, or flank discomfort. His temperature is 37.0°C (98.6°F), blood pressure is 132/84 mmHg, and heart rate is 76/min. Aside from left hip stiffness and an antalgic gait, the physical examination is unremarkable.

Laboratory investigations are obtained as part of standard preoperative protocols. A midstream urine sample shows 18 leukocytes/hpf, positive leukocyte esterase, and negative nitrites. A reflex urine culture subsequently isolates >105>10^5 CFU/mL of Extended-Spectrum Beta-Lactamase (ESBL)-producing *Escherichia coli*. The isolate is resistant to ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole, but retains susceptibility to meropenem, nitrofurantoin, and fosfomycin.

Based on these findings, which of the following is the most appropriate next step in the management of this patient's urinary findings?

Cevabı ve açıklamayı göster

Cevap: Proceed with the scheduled surgery without targeted urinary antimicrobial therapy

Cevap

The most appropriate action is to proceed with the scheduled surgery without targeted urinary antimicrobial therapy.
The correct course of action is to proceed with the scheduled hip arthroplasty without prescribing targeted antibiotics for the urine. This patient's presentation meets the criteria for asymptomatic bacteriuria (ASB): bacterial growth of >105>10^5 CFU/mL in the absence of localized or systemic symptoms of a urinary tract infection. The Infectious Diseases Society of America (IDSA) explicitly recommends against screening for or treating ASB in patients undergoing non-urologic surgeries, including orthopedic joint replacements. Numerous large cohort studies have demonstrated that preoperative ASB is not a significant risk factor for prosthetic joint infection, and eradicating the bacteriuria prior to surgery does not improve surgical outcomes. While the presence of an ESBL-producing organism might seem alarming, treating colonization only exposes the patient to adverse drug effects, increases the risk of *Clostridioides difficile* infection, and promotes further antimicrobial resistance. Pyuria frequently accompanies ASB in older adults and is not an independent indication for treatment.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and laboratory results.
The patient has >105>10^5 CFU/mL of ESBL-producing E. coli and pyuria, but entirely lacks signs or symptoms of a urinary tract infection (no dysuria, urgency, or fever).
Differentiating between asymptomatic bacteriuria (ASB) and a symptomatic UTI is the foundational step in urinary diagnostics.
2
Determine the significance of pyuria in this context.
Pyuria (18 leukocytes/hpf) is recognized as a common accompanying finding in ASB, particularly in the elderly, and does not alter the diagnosis.
Many clinicians erroneously believe pyuria mandates treatment; it is an expected inflammatory response to colonization.
3
Apply current treatment guidelines for ASB in the setting of upcoming surgery.
Guidelines strictly advise against treating ASB prior to non-urologic surgeries, including orthopedic joint replacements.
Treatment does not reduce the risk of prosthetic joint infections and unnecessarily drives antibiotic resistance.

Anahtar Kavram

Asymptomatic bacteriuria (ASB) does not require treatment prior to non-urologic surgeries, such as orthopedic joint arthroplasty, regardless of the organism's antimicrobial resistance profile or the presence of pyuria.
Soru 334Soru →

Match each clinical presentation of infective endocarditis with the most appropriate empiric or targeted antimicrobial regimen.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 55-year-old man with native valve endocarditis caused by methicillin-susceptible Staphylococcus aureus (MSSA) and no known drug allergies.
A 68-year-old woman with suspected prosthetic valve endocarditis, presenting with fever and a new murmur 3 months after a surgical aortic valve replacement.
A 72-year-old man with native valve endocarditis caused by Enterococcus faecalis and a history of severe chronic kidney disease.
A 45-year-old woman with subacute native valve endocarditis caused by Streptococcus gallolyticus that is highly susceptible to penicillin.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches are: Native valve MSSA endocarditis pairs with IV cefazolin or nafcillin; early prosthetic valve endocarditis pairs with IV vancomycin, gentamicin, and rifampin; Enterococcal endocarditis in a patient with chronic kidney disease pairs with IV ampicillin plus ceftriaxone; and highly penicillin-susceptible Streptococcus gallolyticus endocarditis pairs with IV penicillin G or ceftriaxone monotherapy.
Each pathogen and clinical scenario in infective endocarditis requires a specific, guideline-directed antimicrobial regimen to ensure bactericidal activity, penetrate biofilms on prostheses, and minimize systemic toxicity.

Adım Adım Çözüm

1
Analyze the antimicrobial requirement for MSSA native valve endocarditis.
Identify that beta-lactam therapy (nafcillin, oxacillin, or cefazolin) is superior to vancomycin.
Beta-lactams provide faster bacteremia clearance and better clinical outcomes for MSSA infections.
2
Evaluate the patient with suspected early prosthetic valve endocarditis (PVE).
Select a broad-spectrum, three-drug regimen: vancomycin, gentamicin, and rifampin.
Early PVE is frequently caused by coagulase-negative staphylococci; vancomycin provides MRSA/MRSE coverage, rifampin penetrates biofilms, and gentamicin provides early synergy.
3
Assess the treatment for Enterococcus faecalis endocarditis in a patient with severe chronic kidney disease.
Select ampicillin combined with ceftriaxone.
Enterococci require synergistic therapy for bactericidal activity. Ampicillin plus ceftriaxone avoids the nephrotoxicity associated with the alternative ampicillin plus gentamicin regimen.
4
Review the optimal therapy for highly penicillin-susceptible Streptococcus gallolyticus endocarditis.
Select monotherapy with penicillin G or ceftriaxone.
Monotherapy is highly effective for exquisitely susceptible streptococci and avoids unnecessary exposure to broader-spectrum agents or aminoglycosides.

Anahtar Kavram

Appropriate antimicrobial selection for infective endocarditis depends heavily on the causative pathogen, the presence of prosthetic material (requiring biofilm penetration), and patient-specific comorbidities such as underlying renal dysfunction.
Soru 335Soru →

A 68-year-old man is evaluated in the intensive care unit for worsening oxygenation and a new-onset fever. He was admitted 8 days ago for severe acute respiratory distress syndrome secondary to influenza A, requiring endotracheal intubation and mechanical ventilation. Over the past 48 hours, his fraction of inspired oxygen (FiO2) requirement has increased from 40% to 60%. His temperature is 39.1°C (102.4°F), blood pressure is 110/65 mm Hg, and pulse is 108/min. Physical examination reveals coarse rhonchi bilaterally and copious, purulent secretions from the endotracheal tube. A chest radiograph demonstrates a new consolidation in the left lower lobe. Endotracheal aspirate and blood cultures are obtained. The patient is empirically started on intravenous piperacillin-tazobactam, vancomycin, and amikacin. Three days later, his clinical condition has significantly improved, and his oxygen requirements have decreased. The endotracheal aspirate culture yields heavy growth of Pseudomonas aeruginosa. Susceptibility testing indicates the isolate is sensitive to piperacillin-tazobactam, ceftazidime, cefepime, and ciprofloxacin, but resistant to amikacin. Blood cultures show no growth after 72 hours. Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Discontinue vancomycin and amikacin, and continue piperacillin-tazobactam monotherapy

Cevap

Discontinue vancomycin and amikacin, and continue piperacillin-tazobactam monotherapy
The core principle of antimicrobial stewardship in the intensive care unit is de-escalation. The patient's empiric regimen appropriately covered methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Once endotracheal aspirate cultures identified only Pseudomonas aeruginosa susceptible to piperacillin-tazobactam, MRSA coverage (vancomycin) must be discontinued. For definitive treatment of ventilator-associated pneumonia caused by Pseudomonas, a single active beta-lactam agent (in this case, piperacillin-tazobactam) is recommended. The addition of a second agent (such as an aminoglycoside or fluoroquinolone) is not indicated for definitive therapy unless the isolate is highly resistant to beta-lactams, and in this specific scenario, the isolate is resistant to the empirically chosen aminoglycoside anyway.

Adım Adım Çözüm

1
Identify the clinical condition based on the presentation.
The patient developed a new fever, increased oxygen requirements, purulent secretions, and a new pulmonary infiltrate 8 days after intubation, consistent with a diagnosis of ventilator-associated pneumonia (VAP).
Establishing the diagnosis determines the required initial empiric antibiotic spectrum.
2
Evaluate the initial empiric therapy.
Empiric coverage appropriately included agents targeting MRSA (vancomycin) and providing double coverage for Pseudomonas aeruginosa (piperacillin-tazobactam and amikacin) given the patient's risk factors.
Current guidelines recommend broad initial coverage for VAP until causative organisms are identified.
3
Analyze the lower respiratory tract culture and susceptibility data.
The culture confirms Pseudomonas aeruginosa that is sensitive to piperacillin-tazobactam but resistant to amikacin. No MRSA was isolated.
Definitive therapy must be tailored based on microbiologic data to ensure efficacy and minimize toxicity.
4
Apply antimicrobial stewardship principles to modify the regimen.
Discontinue vancomycin (no MRSA isolated) and discontinue amikacin (isolate is resistant). Continue piperacillin-tazobactam as monotherapy.
For definitive treatment of VAP caused by Pseudomonas aeruginosa, de-escalation to a single active beta-lactam agent is standard practice. Double coverage is not routinely recommended for definitive therapy.

Anahtar Kavram

De-escalation of empiric broad-spectrum antibiotics to targeted monotherapy in ventilator-associated pneumonia once culture and susceptibility data are available.
Soru 336Soru →

A 42-year-old woman with acute myeloid leukemia presents to the emergency department with a fever. She received her last cycle of induction chemotherapy 12 days ago. She reports no cough, dyspnea, abdominal pain, or dysuria. Her temperature is 38.8°C (101.8°F), blood pressure is 118/76 mm Hg, pulse is 98/min, and respirations are 16/min. Physical examination reveals a right internal jugular totally implantable venous access port with no overlying erythema, induration, or tenderness. The lungs are clear to auscultation. There are no oral ulcers or skin rashes. Laboratory studies show:

Hemoglobin: 9.2 g/dL
Leukocyte count: 400/mm³
Absolute neutrophil count: 120/mm³
Platelet count: 45,000/mm³

Blood and urine cultures have been obtained. Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Administer intravenous cefepime

Cevap

Administer intravenous cefepime
The correct response is to administer intravenous cefepime. This patient has febrile neutropenia, an oncologic emergency requiring prompt administration of empiric antibiotics after obtaining blood cultures. Because she recently underwent induction chemotherapy for acute myeloid leukemia, her neutropenia is expected to be prolonged (>7 days) and profound, placing her in the high-risk category. High-risk patients must receive intravenous antipseudomonal monotherapy. Acceptable agents include cefepime, meropenem, or piperacillin-tazobactam. The patient lacks indications for the upfront addition of vancomycin.

Adım Adım Çözüm

1
Calculate the absolute neutrophil count (ANC) and define the clinical syndrome.
The patient has a fever (38.8°C) and an ANC of 120/mm³.
Febrile neutropenia is defined as a single oral temperature of ≥ 38.3°C (101°F) or a sustained temperature of ≥ 38.0°C (100.4°F) for over 1 hour in a patient with an ANC < 500/mm³ (or anticipated to decrease to < 500/mm³).
2
Stratify the patient's risk to determine the route and setting of antibiotic administration.
The patient is high-risk due to profound (ANC < 100/mm³ or expected to be) and prolonged (> 7 days) neutropenia associated with acute myeloid leukemia induction therapy.
High-risk patients require admission (if not already hospitalized) and immediate intravenous broad-spectrum antibiotics.
3
Select the appropriate initial empiric antibiotic regimen.
Intravenous cefepime (an antipseudomonal beta-lactam) is selected.
Initial therapy must cover Gram-negative organisms, particularly Pseudomonas aeruginosa. Routine addition of Gram-positive coverage (vancomycin) is not indicated unless specific risk factors (e.g., hypotension, port-site infection, severe mucositis) are present.

Anahtar Kavram

High-risk febrile neutropenia requires immediate empiric intravenous therapy with an antipseudomonal beta-lactam, avoiding routine initial use of vancomycin or antifungals unless specific indications exist.
Soru 337Soru →

A 65-year-old man is brought to the emergency department by his family due to a severe headache, fever, and progressive confusion over the past 12 hours. His temperature is 39.2°C (102.6°F), blood pressure is 110/70 mmHg, pulse is 112/min, and respiratory rate is 18/min. On examination, the patient is lethargic and oriented only to person. Neck flexion produces involuntary hip and knee flexion. Fundoscopic examination reveals blurring of the optic disc margins bilaterally. He has a medical history of type 2 diabetes mellitus and hypertension.

Arrange the following next steps in the management of this patient in the most appropriate chronological order.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first obtain blood cultures, immediately administer empiric antibiotics and dexamethasone, then obtain a CT scan of the head, followed by a lumbar puncture, and finally tailor therapy based on culture results.
The correct chronological sequence begins with obtaining blood cultures to maximize diagnostic yield. Because this patient has papilledema and altered mental status, a CT scan of the head is required before a lumbar puncture to avoid herniation. Crucially, empiric antibiotics (including ampicillin for Listeria in a patient >50 years old) and dexamethasone must be administered immediately after blood cultures and MUST NOT be delayed while waiting for the CT scan. Once the CT scan confirms safety, the lumbar puncture is performed. Finally, therapy is tailored once culture and susceptibility results return.

Adım Adım Çözüm

1
Identify the clinical syndrome and its complications.
The patient has signs of bacterial meningitis (fever, headache, nuchal rigidity/Brudzinski sign) complicated by signs of increased intracranial pressure (papilledema, lethargy).
Recognizing elevated intracranial pressure dictates whether a lumbar puncture can be performed safely or if neuroimaging is required first.
2
Determine the safety of an immediate lumbar puncture.
Lumbar puncture must be delayed until a CT scan of the head rules out a mass effect.
Performing a lumbar puncture in the setting of papilledema and altered mental status carries a high risk of fatal cerebral herniation.
3
Sequence the interventions to prevent treatment delays.
Blood cultures must be drawn STAT, followed immediately by empiric antibiotics and dexamethasone, before sending the patient for the CT scan.
Delaying antibiotics for neuroimaging or cerebrospinal fluid collection significantly increases morbidity and mortality in bacterial meningitis. Blood cultures can be drawn in minutes and should precede antibiotics.

Anahtar Kavram

In patients with suspected bacterial meningitis who have indications for a CT scan before lumbar puncture (e.g., papilledema, altered mental status, new-onset seizure, focal neurologic deficit), blood cultures and empiric antibiotics must be administered immediately and never delayed for neuroimaging.
Soru 338Soru →

A 28-year-old woman is evaluated in the hospital on the third day of admission for acute pyelonephritis. On admission, she presented with fever, chills, right-sided flank pain, and dysuria. She was started on empiric intravenous ceftriaxone. Today, she reports feeling much better and has been afebrile for the past 24 hours. Her right costovertebral angle tenderness has largely resolved. She is tolerating a regular diet.

Urine culture obtained on admission has grown >10510^5 CFU/mL of *Klebsiella pneumoniae*. Antimicrobial susceptibility testing results are as follows:

AntimicrobialInterpretation
AmpicillinResistant
CefazolinSusceptible
CeftriaxoneSusceptible
CiprofloxacinSusceptible
NitrofurantoinSusceptible
Trimethoprim-sulfamethoxazoleSusceptible

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Transition to oral ciprofloxacin

Cevap

Transition to oral ciprofloxacin
The correct action is to transition the patient to oral ciprofloxacin. This patient with acute pyelonephritis has demonstrated significant clinical improvement after initial intravenous therapy. She is hemodynamically stable, has been afebrile for 24 hours, and is tolerating oral intake. These meet the standard clinical criteria for transitioning from intravenous to oral antibiotics, which reduces hospital length of stay and minimizes the risk of line-associated complications. Fluoroquinolones (such as ciprofloxacin or levofloxacin) and trimethoprim-sulfamethoxazole are the preferred oral agents for pyelonephritis because they achieve excellent bioavailability and high therapeutic concentrations in the renal parenchyma. Since the isolated pathogen is susceptible, oral ciprofloxacin is a highly appropriate choice to complete her treatment course.

Adım Adım Çözüm

1
Assess the patient's clinical trajectory and criteria for transitioning to oral therapy.
The patient is afebrile, clinically improving, and tolerating oral intake, indicating readiness for transition from intravenous to oral antibiotics.
Continuing intravenous therapy when oral transition criteria are met increases hospital stay and complication risks.
2
Evaluate the urine culture susceptibility panel to select an appropriate oral agent.
The pathogen is susceptible to several oral options, including ciprofloxacin, nitrofurantoin, and trimethoprim-sulfamethoxazole.
A targeted, narrow-spectrum agent must be chosen based on in vitro susceptibility.
3
Filter the susceptible oral agents based on their pharmacokinetic ability to penetrate renal tissue.
Ciprofloxacin achieves excellent renal tissue penetration, whereas nitrofurantoin does not.
Treating upper urinary tract infections (pyelonephritis) requires an antibiotic that reaches high concentrations in the renal parenchyma.

Anahtar Kavram

Patients with acute pyelonephritis who are clinically improving and tolerating oral intake should be transitioned to oral antibiotics with high renal tissue penetration, such as fluoroquinolones (ciprofloxacin) or trimethoprim-sulfamethoxazole. Nitrofurantoin is contraindicated as it does not achieve adequate levels in the kidney.
Soru 339Soru →

A 54-year-old man is evaluated in the hospital on hospital day 3 for ongoing management of a severe skin and soft tissue infection of the right lower extremity. He initially presented with high fever, chills, and a rapidly expanding area of erythema and induration. Blood cultures drawn on admission have now returned positive for methicillin-susceptible Staphylococcus aureus (MSSA). His empiric antimicrobial regimen since admission has consisted of intravenous vancomycin and cefepime. The patient's medical record indicates an allergy to penicillin, which he describes as a flat, red rash on his chest that occurred 20 years ago when taking amoxicillin. He explicitly denies any history of facial swelling, hives, or breathing difficulties. He is currently hemodynamically stable, his temperature is 37.4°C (99.3°F), and the erythema has significantly receded. Subsequent blood cultures drawn 48 hours after admission show no growth to date.

Which of the following is the most appropriate pharmacologic intervention at this time?

Cevabı ve açıklamayı göster

Cevap: Replace the current antimicrobials with intravenous cefazolin

Cevap

Replace the current antimicrobials with intravenous cefazolin
The patient has MSSA bacteremia secondary to a skin and soft tissue infection. The drug of choice for MSSA bacteremia is an anti-staphylococcal beta-lactam, such as cefazolin or nafcillin, because these agents have been shown to provide superior clinical outcomes, faster bacterial clearance, and lower mortality compared to vancomycin. A critical decision point in this vignette is the patient's reported penicillin allergy. He experienced a non-pruritic maculopapular rash to amoxicillin 20 years ago. This is a classic non-IgE-mediated, delayed-type hypersensitivity reaction that is generally benign. Furthermore, cefazolin has a unique R1 side chain that is structurally distinct from other penicillins and cephalosporins, making the rate of cross-reactivity virtually non-existent. Therefore, the most appropriate next step in antibiotic stewardship is to de-escalate his broad-spectrum empiric regimen and transition him to intravenous cefazolin monotherapy.

Adım Adım Çözüm

1
Analyze the culture and susceptibility results.
The pathogen is identified as methicillin-susceptible Staphylococcus aureus (MSSA).
Guides targeted antimicrobial de-escalation from empiric broad-spectrum therapy.
2
Evaluate the patient's penicillin allergy history.
The history of a flat, red rash 20 years ago indicates a delayed, non-IgE-mediated reaction rather than anaphylaxis.
Determines the safety of administering beta-lactam antibiotics, which are the treatment of choice for MSSA.
3
Select the optimal targeted therapy for MSSA bacteremia.
Intravenous cefazolin is selected as the definitive therapy.
Anti-staphylococcal beta-lactams are superior to vancomycin for MSSA, and cefazolin poses virtually zero cross-reactivity risk given its unique side chain.

Anahtar Kavram

Patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia should be treated with an anti-staphylococcal beta-lactam (e.g., cefazolin, nafcillin) rather than vancomycin due to superior clinical outcomes. A remote, non-IgE-mediated penicillin allergy is not a contraindication to cefazolin.
Tahmini Süre:1m 15s
Soru 340Soru →

An 82-year-old woman is brought to the emergency department from a skilled nursing facility due to a 2-day history of worsening confusion and agitation. She has a medical history of moderate Alzheimer dementia, type 2 diabetes mellitus, hypertension, and urge urinary incontinence. Two weeks ago, she was evaluated for worsening incontinence, and oral oxybutynin was added to her regimen. She cannot provide a reliable history, but the facility staff reports no observed coughing, vomiting, diarrhea, or signs of pain during urination. The staff did note that her urine has been cloudy and malodorous for the past 3 days.

Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 138/84 mmHg138/84\text{ mmHg}, pulse 88/min88/\text{min}, and respiratory rate 16/min16/\text{min}. Oxygen saturation is 98%98\% on room air. The patient is disoriented to time and place and frequently picks at her clothing. The abdomen is soft, non-tender, and without suprapubic distension. Bilateral costovertebral angle percussion elicits no reaction.

Laboratory evaluation shows a leukocyte count of 8,500/mm38,500/\text{mm}^3, serum sodium of 138 mEq/L138\text{ mEq/L}, serum creatinine of 1.0 mg/dL1.0\text{ mg/dL}, and blood glucose of 115 mg/dL115\text{ mg/dL}. Urinalysis obtained via straight catheterization reveals:

Color: Yellow, cloudy
Specific gravity: 1.0181.018
Leukocyte esterase: Positive
Nitrites: Positive
WBCs: 30-40/hpf30\text{-}40/\text{hpf}
RBCs: 0-2/hpf0\text{-}2/\text{hpf}
Bacteria: Many

A urine culture is sent to the laboratory. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Withhold antimicrobial therapy and evaluate for alternative etiologies of altered mental status

Cevap

Withhold antimicrobial therapy and evaluate for alternative etiologies of altered mental status
The most appropriate next step is to withhold antimicrobial therapy and evaluate for alternative etiologies of her altered mental status. This patient presents with acute delirium and a positive urinalysis. However, up to 50%50\% of elderly female nursing home residents have asymptomatic bacteriuria (ASB). According to current infectious disease guidelines, ASB should not be screened for or treated, even in older patients presenting with altered mental status, provided they lack systemic signs of infection (e.g., fever, hemodynamic instability, marked leukocytosis) and focal genitourinary symptoms (e.g., dysuria, suprapubic pain, costovertebral angle tenderness). Furthermore, cloudy and malodorous urine does not constitute a focal symptom and is not an indication for antibiotics. Treating ASB does not improve clinical outcomes and increases the risk of antimicrobial resistance, adverse drug reactions, and *Clostridioides difficile* infection. Instead of anchoring on the positive urinalysis, clinicians should search for alternative causes of delirium. In this patient, the recent initiation of oxybutynin (a medication with strong anticholinergic properties) is the highly likely culprit for her acute cognitive decline.

Adım Adım Çözüm

1
Evaluate the patient's vital signs and physical examination for evidence of a true symptomatic infection.
The patient has altered mental status but no localizing genitourinary symptoms (e.g., suprapubic pain, costovertebral angle tenderness) or systemic signs of infection (e.g., fever, tachycardia, marked leukocytosis).
Distinguishing true infection from asymptomatic colonization requires assessing for systemic and localizing clinical signs, particularly in elderly patients with baseline cognitive impairment.
2
Analyze the urinalysis findings in the context of the clinical presentation.
The urinalysis is positive for leukocytes, nitrites, and bacteria, confirming the presence of bacteriuria.
While the urinalysis shows bacteriuria, cloudy and malodorous urine alone without systemic or localizing inflammatory signs does not diagnose a symptomatic infection in this demographic.
3
Identify alternative non-infectious causes for the patient's acute delirium.
The patient was recently started on oxybutynin, an antispasmodic medication with strong anticholinergic properties that carries a high risk of inducing acute delirium in the elderly.
Recognizing adverse medication effects is crucial to avoid inappropriate anchoring on a false-positive infectious workup.
4
Determine the most appropriate management plan based on antimicrobial stewardship guidelines.
Antibiotics are withheld, and a workup for alternative etiologies (including addressing the anticholinergic medication) is pursued.
Treating asymptomatic bacteriuria in the elderly does not improve clinical outcomes and inappropriately promotes antimicrobial resistance.

Anahtar Kavram

In elderly patients with altered mental status but no systemic or focal genitourinary symptoms, a positive urinalysis typically represents asymptomatic bacteriuria and should not be treated with antibiotics. Alternative causes for delirium, such as anticholinergic medications, should be aggressively investigated.
ÖncekiSayfa 17 / 26Sonraki
Infectious Diseases Alıştırma Soruları — USMLE Step 2 CK — Sayfa 17 | Examkin